Vuzix Corporation — Q2 2023 Form 10-Q
Reporting period: Three and six months ended June 30, 2023; comparisons are to the corresponding 2022 periods. Vuzix designs, manufactures, markets and sells smart glasses and augmented-reality display technology, and provides related engineering services. Figures below are unaudited.
Financial performance and liquidity
| Metric | Q2 2023 | Six months 2023 |
|---|---|---|
| Revenue | $4.69 million | $8.88 million |
| Gross profit / margin | $0.97 million / 21% | $1.85 million / 21% |
| Operating loss | $9.61 million | $20.45 million |
| Net loss | $9.04 million | $19.29 million |
| Loss per share, basic and diluted | $0.14 | $0.31 |
| Operating cash flow | Not separately reported for the quarter | $(12.09) million |
| Investing cash flow | Not separately reported for the quarter | $(11.44) million |
| Cash and cash equivalents at June 30 | $48.58 million |
Q2 revenue increased 56% year over year, led by smart-glasses sales, particularly higher M400 unit sales. Product revenue was $4.43 million and engineering-services revenue was $0.27 million. H1 revenue grew 61%; management noted higher average discounts associated with larger-volume reseller sales.
Cash declined $23.98 million from December 31, 2022. At June 30, current assets were $68.32 million and current liabilities were $6.83 million, yielding working capital of $61.50 million, down from $75.96 million at year-end. The company reported no current or long-term debt obligations, apart from $3.50 million of current licensing-fee commitments. Operating lease liabilities totaled $0.63 million.
Changes versus prior comparable periods
- Q2 gross margin rose to 21% from 9%; H1 gross margin rose to 21% from 13%. Higher sales and lower cost of sales as a percentage of revenue contributed to the improvement.
- Q2 net loss narrowed to $9.04 million from $10.02 million; H1 net loss narrowed to $19.29 million from $20.53 million. H1 operating loss was essentially unchanged at $20.45 million versus $20.41 million.
- Operating expenses included higher selling and marketing costs, while research and development and general and administrative costs declined. Depreciation and amortization rose substantially, mainly reflecting amortization of Atomistic technology licenses.
- H1 investment income increased to $1.32 million from $0.12 million, primarily due to higher interest earned on excess cash; this helped reduce net loss but did not prevent operating cash outflow.
Outlook, risks and notable items
- The filing provides no specific revenue, earnings, margin or cash-flow guidance. Management identifies the sufficiency of cash for at least the next 12 months as a forward-looking matter, rather than presenting a definitive forecast.
- Management expects construction of the new facility to be completed by the end of September 2023. H1 spending included $2.77 million on manufacturing equipment and leasehold improvements, primarily for waveguide expansion.
- The Atomistic micro-LED technology agreements carry a remaining $3.50 million cash funding commitment expected to be paid over the next six months. Upon specified deliverables and milestones, Vuzix also may owe $2.50 million and issue 1.75 million to 2.87 million shares over the next 6 to 18 months.
- Customer concentration is significant: one customer accounted for 75% of Q2 product revenue. At June 30, two customers represented 58% and 23% of accounts receivable. Management also cites reliance on key customers, suppliers and manufacturing capacity; rapid technological change; competition; order timing; inventory and product-supply execution; and foreign-exchange exposure.
- H1 operating cash use was $12.09 million and investing cash use was $11.44 million. The company reported $6.50 million of H1 stock-based compensation; some LTIP milestones currently not considered probable could result in up to a further $34.1 million of non-cash compensation expense if they become probable or are achieved.
- Inventory obsolescence reserve increased to $1.90 million from $1.42 million at year-end. The company reported no material pending legal proceedings and no material changes to the risk factors in its 2022 Form 10-K. Disclosure controls were assessed as effective at June 30, 2023.
Important facts for investors to verify
- Whether M400 demand and revenue growth continue, and how customer concentration and reseller discounts affect sales and margins.
- Cash burn, working-capital movements and the company’s ability to fund operating losses, waveguide expansion and licensing commitments.
- Progress and completion costs for the new facility, manufacturing capacity and supply-chain constraints.
- Achievement and timing of Atomistic milestones, including the associated cash payments and potential share issuance.
- Inventory valuation, the obsolescence reserve and the potential scale and timing of LTIP stock-based compensation.